Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Muraglitazar Alone or with Pravastatin in Mixed Dyslipidemia
NCT00245388Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of muraglitazar in mixed dyslipidemia, sponsored by Bristol Myers Squibb. Started Apr 2002; status: completed.
02
Drugs
muraglitazar
03
Conditions
mixed dyslipidemia
Beyond the preview
Go deeper on NCT00245388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245388.